UK markets closed
  • NIKKEI 225

    26,490.53
    +382.88 (+1.47%)
     
  • HANG SENG

    21,643.58
    +56.92 (+0.26%)
     
  • CRUDE OIL

    103.87
    +5.34 (+5.42%)
     
  • GOLD FUTURES

    1,741.30
    +4.80 (+0.28%)
     
  • DOW

    31,295.45
    +257.77 (+0.83%)
     
  • BTC-GBP

    17,555.20
    +602.63 (+3.55%)
     
  • CMC Crypto 200

    459.70
    +15.38 (+3.46%)
     
  • ^IXIC

    11,584.52
    +222.67 (+1.96%)
     
  • ^FTAS

    3,956.98
    +46.18 (+1.18%)
     

Global Arthritis Monoclonal Antibodies Markets 2022-2031: Focus on Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia

·4-min read
Company Logo
Company Logo

Global Arthritis Monoclonal Antibodies Market

Global Arthritis Monoclonal Antibodies Market
Global Arthritis Monoclonal Antibodies Market

Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Arthritis Monoclonal Antibodies Global Market Report 2022: By Drug, By Application, By End-Use" report has been added to ResearchAndMarkets.com's offering.

Arthritis Monoclonal Antibodies Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global arthritis monoclonal antibodies (mab's) market.

This report focuses on arthritis monoclonal antibodies (mab's) market which is experiencing strong growth. The report gives a guide to the arthritis monoclonal antibodies (mab's) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider arthritis monoclonal antibodies (mab's) market, and compares it with other markets.

Where is the largest and fastest growing market for the arthritis monoclonal antibodies (mab's)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Arthritis Monoclonal Antibodies (mab's) market global report answers all these questions and many more.

The countries covered in the arthritis monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Report Scope

  • The market characteristics section of the report defines and explains the market

  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth

  • Market segmentations break down market into sub markets

  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets

  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified

  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers

  • The arthritis monoclonal antibodies (mab's) market section of the report gives context. It compares the arthritis monoclonal antibodies (mab's) market with other segments of the arthritis monoclonal antibodies (mab's) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, arthritis monoclonal antibodies (mab's) indicators comparison

Markets Covered:

  • By Drug: Remicade; Humira; Enbrel; Rituxan; Orencia; Actemra; Simponi; Cimzia; Remsima

  • By Application: Rheumatoid Arthritis; Osteoarthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Fibromyalgia; Others

  • By End-Use: Hopitals; Research Institutes; Others

Major Companies Mentioned:

  • Johnson & Johnson

  • Roche

  • Novartis

  • Pfizer Inc

  • AbbVie Inc

Key Topics Covered:

1. Executive Summary

2. Arthritis Monoclonal Antibodies Market Characteristics

3. Arthritis Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Arthritis Monoclonal Antibodies

5. Arthritis Monoclonal Antibodies Market Size And Growth
5.1. Global Arthritis Monoclonal Antibodies Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Arthritis Monoclonal Antibodies Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Arthritis Monoclonal Antibodies Market Segmentation
6.1. Global Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Remicade

  • Humira

  • Enbrel

  • Rituxan

  • Orencia

  • Actemra

  • Simponi

  • Cimzia

  • Remsima

6.2. Global Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Rheumatoid Arthritis

  • Osteoarthritis

  • Psoriatic Arthritis

  • Ankylosing Spondylitis

  • Fibromyalgia

  • Others

6.3. Global Arthritis Monoclonal Antibodies Market, Segmentation By End-use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Hopitals

  • Research Institutes

  • Others

7. Arthritis Monoclonal Antibodies Market Regional And Country Analysis
7.1. Global Arthritis Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Arthritis Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

  • Johnson & Johnson

  • Roche

  • Novartis

  • Pfizer inc.

  • AbbVie inc.

  • Amgen inc.

  • Genentech

  • GSK

  • AstraZeneca plc.

  • Mylan N.V.

  • Bristol Myers Squibb

  • Eli Lily and Company

  • Thermofischer Scientific

  • Sanofi

  • Novo Nordisk A/S

  • Daiichi Sankyo Company ltd.

  • Seattle genetics

  • Teva pharmaceutical industries

  • Shanghi Junsi bioscience ltd.

  • GenScript

  • Sigma-Aldrich Co. LLC

  • AbGenomics

  • ADC Therapeutics

  • Agensys

  • Alexion Pharmaceuticals

  • ALMAC Group

  • Ambrx

  • Astellas Pharma

  • Celgene

  • Celldex Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/edvcu2

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting